Oramed Pharmaceuticals
ORMP
ORMP
21 hedge funds and large institutions have $910K invested in Oramed Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
91% less call options, than puts
Call options by funds: $3K | Put options by funds: $32K
Holders
21
Holding in Top 10
–
Calls
$3K
Puts
$32K
Top Buyers
| 1 | +$184K | |
| 2 | +$37.2K | |
| 3 | +$18.2K | |
| 4 |
PCM
Penserra Capital Management
Orinda,
California
|
+$10.7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.25K |
Top Sellers
| 1 | -$85K | |
| 2 | -$31.1K | |
| 3 | -$21K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$18K |
| 5 |
Morgan Stanley
New York
|
-$17.4K |